Insertion of an SVA-E retrotransposon into theCASP8gene is associated with protection against prostate cancer
Adult
Male
0301 basic medicine
570
RNA Splicing
Molecular Sequence Data
610
Breast Neoplasms
Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences
Polymorphism, Single Nucleotide
03 medical and health sciences
Odds Ratio
Humans
name=Centre for Surgical Research
Alleles
Aged
Aged, 80 and over
Caspase 8
Base Sequence
Association Studies Articles
Prostatic Neoplasms
/dk/atira/pure/core/keywords/centre_for_surgical_research; name=Centre for Surgical Research
Middle Aged
Protective Factors
Introns
3. Good health
Carcinoma, Basal Cell
Female
/dk/atira/pure/core/keywords/centre_for_surgical_research
Genome-Wide Association Study
DOI:
10.1093/hmg/ddv622
Publication Date:
2016-01-07T01:28:52Z
AUTHORS (44)
ABSTRACT
Transcriptional and splicing anomalies have been observed in intron 8 of the CASP8 gene (encoding procaspase-8) in association with cutaneous basal-cell carcinoma (BCC) and linked to a germline SNP rs700635. Here, we show that the rs700635[C] allele, which is associated with increased risk of BCC and breast cancer, is protective against prostate cancer [odds ratio (OR) = 0.91, P = 1.0 × 10(-6)]. rs700635[C] is also associated with failures to correctly splice out CASP8 intron 8 in breast and prostate tumours and in corresponding normal tissues. Investigation of rs700635[C] carriers revealed that they have a human-specific short interspersed element-variable number of tandem repeat-Alu (SINE-VNTR-Alu), subfamily-E retrotransposon (SVA-E) inserted into CASP8 intron 8. The SVA-E shows evidence of prior activity, because it has transduced some CASP8 sequences during subsequent retrotransposition events. Whole-genome sequence (WGS) data were used to tag the SVA-E with a surrogate SNP rs1035142[T] (r(2) = 0.999), which showed associations with both the splicing anomalies (P = 6.5 × 10(-32)) and with protection against prostate cancer (OR = 0.91, P = 3.8 × 10(-7)).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (26)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....